ZA985395B - Use of intravenous contrast media and apparatus for projection mammography - Google Patents

Use of intravenous contrast media and apparatus for projection mammography

Info

Publication number
ZA985395B
ZA985395B ZA985395A ZA985395A ZA985395B ZA 985395 B ZA985395 B ZA 985395B ZA 985395 A ZA985395 A ZA 985395A ZA 985395 A ZA985395 A ZA 985395A ZA 985395 B ZA985395 B ZA 985395B
Authority
ZA
South Africa
Prior art keywords
projection mammography
intravenous
mammography
projection
intravenous contrast
Prior art date
Application number
ZA985395A
Other languages
English (en)
Inventor
Ulrich Speck
Alexander Irtel Von Brenndorff
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of ZA985395B publication Critical patent/ZA985395B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0433X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0457Semi-solid forms, ointments, gels, hydrogels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
ZA985395A 1997-06-20 1998-06-19 Use of intravenous contrast media and apparatus for projection mammography ZA985395B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97250190A EP0885616A1 (fr) 1997-06-20 1997-06-20 Utilisation d'agents de contraste à administration intraveneuse, et appareil pour la mammographie

Publications (1)

Publication Number Publication Date
ZA985395B true ZA985395B (en) 1999-04-07

Family

ID=8229158

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA985395A ZA985395B (en) 1997-06-20 1998-06-19 Use of intravenous contrast media and apparatus for projection mammography

Country Status (28)

Country Link
US (2) US20020031475A1 (fr)
EP (3) EP0885616A1 (fr)
JP (3) JP4664449B2 (fr)
KR (2) KR20010013980A (fr)
CN (2) CN1263449A (fr)
AT (1) ATE229820T1 (fr)
AU (2) AU747033B2 (fr)
BG (2) BG64895B1 (fr)
BR (2) BR9810205A (fr)
CA (2) CA2294187A1 (fr)
CZ (1) CZ298462B6 (fr)
DE (1) DE59806743D1 (fr)
DK (1) DK0994729T3 (fr)
HK (1) HK1029759A1 (fr)
HU (2) HU225522B1 (fr)
IL (2) IL133574A (fr)
NO (2) NO315638B1 (fr)
NZ (2) NZ501603A (fr)
PL (2) PL337286A1 (fr)
RS (1) RS49734B (fr)
RU (1) RU2194533C2 (fr)
SI (2) SI20152A (fr)
SK (2) SK181199A3 (fr)
TR (2) TR199903144T2 (fr)
UA (1) UA71895C2 (fr)
WO (2) WO1998058679A1 (fr)
YU (1) YU66299A (fr)
ZA (1) ZA985395B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10118792B4 (de) * 2001-04-05 2005-12-22 Schering Ag Anordnung zur Aufnahme von Projektionsmammogrammen und Verwendung der Anordnung für die Projektionsmammographie
FR2823969B1 (fr) * 2001-04-30 2003-12-26 Ge Med Sys Global Tech Co Llc Procede de prelevement d'un tissu au cours d'un examen par rayons x et dispositif de mise en oeuvre
DE102005033235A1 (de) * 2005-07-15 2007-01-18 Siemens Ag Verfahren zur Visualisierung eines vaskulären Einsatzstücks
US20080167552A1 (en) * 2007-01-04 2008-07-10 General Electric Company System and method of generating an image of a contrast agent injected into an imaged subject
FR2927719B1 (fr) 2008-02-19 2010-03-26 Gen Electric Procede de traitement d'images obtenues par tomosynthese et dispositif associe
US8315449B2 (en) * 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
JP2012055549A (ja) * 2010-09-10 2012-03-22 Fujifilm Corp バイオプシ用ファントム
FR2967888B1 (fr) * 2010-11-26 2012-12-21 Gen Electric Procede de galactographie et mammographe pour l'execution dudit procede
US9651138B2 (en) 2011-09-30 2017-05-16 Mtd Products Inc. Speed control assembly for a self-propelled walk-behind lawn mower
DE102012217301B4 (de) 2012-09-25 2021-10-14 Bayer Pharma Aktiengesellschaft Kombination aus Kontrastmittel und Mammographie-CT-System mit vorgegebenem Energiebereich und Verfahren zur Erzeugung tomographischer Mammographie-CT-Aufnahmen durch diese Kombination
EA036245B1 (ru) * 2017-10-26 2020-10-16 Казахский научно-исследовательский институт онкологии и радиологии Способ диагностики рака молочной железы
EP3498306A1 (fr) * 2017-12-16 2019-06-19 Bionorica SE Extraits de vitex agnus castus destinés au traitement et au diagnostic du cancer du sein

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4192859A (en) * 1978-09-29 1980-03-11 E. R. Squibb & Sons, Inc. Contrast media containing liposomes as carriers
FR2541272A1 (fr) * 1983-02-23 1984-08-24 Guerbet Sa Composes bromes et produits opacifiants en contenant
WO1987002893A1 (fr) * 1985-11-18 1987-05-21 Board Of Regents, The University Of Texas System Agents polychelateurs pour l'amelioration de l'image et du spectre (et pour derive spectrale)
US5260050A (en) * 1988-09-29 1993-11-09 Ranney David F Methods and compositions for magnetic resonance imaging comprising superparamagnetic ferromagnetically coupled chromium complexes
GB8906130D0 (en) * 1989-03-17 1989-05-04 Nycomed As Compositions
DE3938992A1 (de) * 1989-11-21 1991-05-23 Schering Ag Kaskadenpolymer-gebundene komplexbildner, deren komplexe und konjugate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
US5844965A (en) * 1989-11-24 1998-12-01 Thomas Jefferson University Method and apparatus for using film density measurements of a radiograph to monitor the reproducibility of X-ray exposure parameters of a mammography unit
DE4232925A1 (de) * 1992-09-28 1994-03-31 Diagnostikforschung Inst 3-,8-substituierte Deuteroporphyrinderivate, diese enthaltende pharmazeutische Mittel und Verfahren zu ihrer Herstellung
US5411730A (en) * 1993-07-20 1995-05-02 Research Corporation Technologies, Inc. Magnetic microparticles
DE4417628C1 (de) * 1994-05-19 1995-09-28 Siemens Ag Verfahren zur adaptiven Rauschverminderung für digitale Bildsequenzen
AU4173896A (en) * 1994-11-30 1996-06-19 Schering Aktiengesellschaft Use of chelate compounds as diagnostic agents in the x-ray examination of liver and bile ducts
US5756066A (en) * 1995-06-07 1998-05-26 Schering Aktiengesellschaft Iodine-containing peptides
US5804164A (en) * 1996-03-13 1998-09-08 Research Corporation Technologies, Inc. Water-soluble lipophilic contrast agents
US6009342A (en) * 1997-02-28 1999-12-28 The Regents Of The University Of California Imaging method for the grading of tumors

Also Published As

Publication number Publication date
JP2002505679A (ja) 2002-02-19
NZ501603A (en) 2002-02-01
KR100582980B1 (ko) 2006-05-24
CZ460999A3 (cs) 2000-04-12
NZ501602A (en) 2002-02-01
CN1212862C (zh) 2005-08-03
SK181199A3 (en) 2000-07-11
HUP0003097A1 (hu) 2001-01-29
EP0991356A1 (fr) 2000-04-12
JP4664449B2 (ja) 2011-04-06
RU2194533C2 (ru) 2002-12-20
SI20148A (sl) 2000-08-31
CZ298462B6 (cs) 2007-10-10
JP2002504843A (ja) 2002-02-12
KR20010013980A (ko) 2001-02-26
IL133574A0 (en) 2001-04-30
CA2294502A1 (fr) 1998-12-30
KR20010013979A (ko) 2001-02-26
SK282716B6 (sk) 2002-11-06
CA2294187A1 (fr) 1998-12-30
NO996291D0 (no) 1999-12-17
DK0994729T3 (da) 2003-03-10
NO996292D0 (no) 1999-12-17
NO996291L (no) 1999-12-17
SI20152A (sl) 2000-08-31
YU66299A (sh) 2002-09-19
UA71895C2 (en) 2005-01-17
EP0885616A1 (fr) 1998-12-23
CN1263474A (zh) 2000-08-16
RS49734B (sr) 2008-04-04
BR9810215A (pt) 2000-08-08
PL337286A1 (en) 2000-08-14
YU66199A (sh) 2002-10-18
US20020031475A1 (en) 2002-03-14
TR199903140T2 (xx) 2000-05-22
PL191807B1 (pl) 2006-07-31
PL337287A1 (en) 2000-08-14
HU225522B1 (en) 2007-01-29
SK171299A3 (en) 2000-05-16
WO1998058679A1 (fr) 1998-12-30
DE59806743D1 (de) 2003-01-30
NO315638B1 (no) 2003-10-06
CN1263449A (zh) 2000-08-16
IL133573A0 (en) 2001-04-30
JP2011012074A (ja) 2011-01-20
IL133574A (en) 2004-03-28
AU747033B2 (en) 2002-05-09
EP0994729B1 (fr) 2002-12-18
EP0994729A1 (fr) 2000-04-26
AU8337998A (en) 1999-01-04
BG104017A (en) 2000-05-31
BG64895B1 (bg) 2006-08-31
BR9810205A (pt) 2000-08-08
ATE229820T1 (de) 2003-01-15
NO996292L (no) 1999-12-17
WO1998058585A1 (fr) 1998-12-30
AU8627198A (en) 1999-01-04
HUP0003097A3 (en) 2003-07-28
BG104018A (en) 2000-05-31
HUP0003096A1 (hu) 2001-01-29
TR199903144T2 (xx) 2000-08-21
HK1029759A1 (en) 2001-04-12
US20050008574A1 (en) 2005-01-13
CA2294502C (fr) 2009-03-31

Similar Documents

Publication Publication Date Title
NO854765L (no) Anvendelse av ferromagnetiske partikler i kontrastmidler for nmr-avbildning og kontrastmidler.
ZA985395B (en) Use of intravenous contrast media and apparatus for projection mammography
CA2427590A1 (fr) Evaluation de la progression d'une maladie au moyen de l'imagerie par resonance magnetique
AU1047399A (en) Para-hydrogen labelled agents and their use in magnetic resonance imaging
IS4790A (is) Málmsamstæður sem innihalda Perflúoróalkýl og notkun þeirra við segulsneiðmyndunar-greiningar
WO1998058593A3 (fr) Systeme chirurgical guide par images
HK1050898A1 (en) Intermediate used for manufacturing cascade polymer complexes.
WO1999030486A3 (fr) Formation d'une image d'assemblage provenant d'images radiologiques successives
ES2138970T3 (es) Medios de contraste.
ZA92389B (en) Method for detection of anti-rna-antibodies
DE69013088T2 (de) Entwicklungseinheit eines Bilderzeugungsgerätes.
WO2002041776A8 (fr) Ultrasons a l'interieur d'appareils irm permettant de guider des sequences d'impulsion irm
SU959107A1 (ru) Устройство дл считывани информации с перфокарт
ATE411531T1 (de) Auslesereihenfolge beim sammeln radialer magnetresonanz-bilddaten
Lange et al. Some sharpening and registration methods applied to SPECT images of pediatric brain tumors
Ronal EDITOR'S NOTE: Pleaseusecautionwhenrepeatingthisstudy. Duetothemanufacturer'smodification
EP1640737A3 (fr) Evaluation de la progression d'une maladie au moyen de l'imagerie par resonance magnétique
Borris PERSONALITY CHARACTERISTICS DIFFERENTIATING CANCER PATIENTS, PSYCHIATRIC PATIENTS, AND NORMALS.
Pukhlik et al. Immunological and biophysical parallels in estimation of specific reactivity of tuberculous patients.
Harper " G. Richard Dimler, Friedrich Spee von Langenfeld: Eine beschreibende Bibliographie", Part II:" Forschungsliteratur"(Book Review)
IT8900602A0 (it) Dispositivo elettrico ad alta frequenza da utilizzare in medicina per effettuare rilievi diagnostici sull'organismo dei pazienti